Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients-Reference-Cited by-同舟云学术

Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients

Published:2012-01-03 Issue:1 Volume:122 Page:253-266
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Agnihotri Sameer,Gajadhar Aaron S.,Ternamian Christian,Gorlia Thierry,Diefes Kristin L.,Mischel Paul S.,Kelly Joanna,McGown Gail,Thorncroft Mary,Carlson Brett L.,Sarkaria Jann N.,Margison Geoffrey P.,Aldape Kenneth,Hawkins Cynthia,Hegi Monika,Guha Abhijit

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference45 articles.

1. Recent Advances in the Treatment of Malignant Astrocytoma

2. Human Glioma Cell Sensitivity to the Sequence-Specific Alkylating Agent Methyl-Lexitropsin

3. Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase

4. Kleihues P, Cavanee WK.World Health Organization Classification of Tumors: Pathology and Genetic: Tumors of the Nervous System . New York, New York, USA; 2000.

5. Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human translesion DNA polymerases ι and κ mediate tolerance to temozolomide in MGMT-deficient glioblastoma cells.;DNA Repair;2024-09

2. Accidental Encounter of Repair Intermediates in Alkylated DNA May Lead to Double-Strand Breaks in Resting Cells;International Journal of Molecular Sciences;2024-07-26

3. AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma;BMC Cancer;2024-07-24

4. A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors;Neuro-Oncology;2024-07-09

5. Origin recognition complex 6 overexpression promotes growth of glioma cells;Cell Death & Disease;2024-07-06